127 related articles for article (PubMed ID: 27869413)
1. Humoral immunity to tetanus, measles and rubella in children with acute lymphoblastic leukemia after chemotherapy.
Onorateli M; Botana C; Peralta L; Rebollo M; Ruvinsky S; Guitter M; Felice MS; Posadas M; Evangelista S; Villar MV; Golluscio M; Molina A; Fraquelli L
Arch Argent Pediatr; 2016 Dec; 114(6):549-552. PubMed ID: 27869413
[TBL] [Abstract][Full Text] [Related]
2. Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens.
Nilsson A; De Milito A; Engström P; Nordin M; Narita M; Grillner L; Chiodi F; Björk O
Pediatrics; 2002 Jun; 109(6):e91. PubMed ID: 12042585
[TBL] [Abstract][Full Text] [Related]
3. Measles and rubella antibody status in children after treatment for acute lymphoblastic leukemia.
Volc SM; Almeida MT; Abadi MD; Cornacchioni AL; Odone Filho V; Cristofani LM
J Pediatr (Rio J); 2006; 82(6):481-4. PubMed ID: 17003944
[TBL] [Abstract][Full Text] [Related]
4. Differential loss of humoral immunity against measles, mumps, rubella and varicella-zoster virus in children treated for cancer.
Bochennek K; Allwinn R; Langer R; Becker M; Keppler OT; Klingebiel T; Lehrnbecher T
Vaccine; 2014 Jun; 32(27):3357-61. PubMed ID: 24793952
[TBL] [Abstract][Full Text] [Related]
5. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
Zignol M; Peracchi M; Tridello G; Pillon M; Fregonese F; D'Elia R; Zanesco L; Cesaro S
Cancer; 2004 Aug; 101(3):635-41. PubMed ID: 15274078
[TBL] [Abstract][Full Text] [Related]
6. Humoral immunity to diphtheria, tetanus, measles, and hemophilus influenzae type b in children with acute lymphoblastic leukemia and response to re-vaccination.
Zengin E; Sarper N
Pediatr Blood Cancer; 2009 Dec; 53(6):967-72. PubMed ID: 19544393
[TBL] [Abstract][Full Text] [Related]
7. Antibody titers and immune response to diphtheria-tetanus-pertussis and measles-mumps-rubella vaccination in children treated for acute lymphoblastic leukemia.
Ercan TE; Soycan LY; Apak H; Celkan T; Ozkan A; Akdenizli E; Kasapçopur O; Yildiz I
J Pediatr Hematol Oncol; 2005 May; 27(5):273-7. PubMed ID: 15891564
[TBL] [Abstract][Full Text] [Related]
8. [Cytostatic therapy reduces the immune defense. Children treated for leukemia have impaired immunity against measles and rubella].
Nilsson A; Nordin M; De Milito A; Grillner L; Chiodi F; Björk O
Lakartidningen; 2000 Nov; 97(45):5116-8. PubMed ID: 11116890
[TBL] [Abstract][Full Text] [Related]
9. Assessment of immune response following immunization with DTP/Td and MMR vaccines in children treated for acute lymphoblastic leukemia.
Koochakzadeh L; Khosravi MH; Pourakbari B; Hosseinverdi S; Aghamohammadi A; Rezaei N
Pediatr Hematol Oncol; 2014 Oct; 31(7):656-63. PubMed ID: 25007393
[TBL] [Abstract][Full Text] [Related]
10. Measles, mumps, and rubella antibody status and response to immunization in children after therapy for acute lymphoblastic leukemia.
Aytac S; Yalcin SS; Cetin M; Yetgin S; Gumruk F; Tuncer M; Yurdakok K; Gurgey A
Pediatr Hematol Oncol; 2010 Aug; 27(5):333-43. PubMed ID: 20469978
[TBL] [Abstract][Full Text] [Related]
11. Revaccination of children after completion of standard chemotherapy for acute leukemia.
Patel SR; Ortín M; Cohen BJ; Borrow R; Irving D; Sheldon J; Heath PT
Clin Infect Dis; 2007 Mar; 44(5):635-42. PubMed ID: 17278052
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Humoral Immunity to Hepatitis B, Measles, Rubella, and Mumps in Children After Chemotherapy.
Keskin Yildirim Z; Buyukavci M
J Pediatr Hematol Oncol; 2018 Mar; 40(2):e99-e102. PubMed ID: 29309372
[TBL] [Abstract][Full Text] [Related]
13. Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92.
Calaminus G; Hense B; Laws HJ; Groeger M; MacKenzie CR; Göbel U
Klin Padiatr; 2007; 219(6):355-60. PubMed ID: 18050047
[TBL] [Abstract][Full Text] [Related]
14. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
Fioredda F; Giacchino M; Castagnola E
Cancer; 2005 Apr; 103(8):1758-9; author reply 1760. PubMed ID: 15717298
[No Abstract] [Full Text] [Related]
15. Protection against vaccine preventable diseases in children treated for acute lymphoblastic leukemia.
de de la Fuente Garcia I; Coïc L; Leclerc JM; Laverdière C; Rousseau C; Ovetchkine P; Tapiéro B
Pediatr Blood Cancer; 2017 Feb; 64(2):315-320. PubMed ID: 27718310
[TBL] [Abstract][Full Text] [Related]
16. Humoral immune response of childhood acute lymphoblastic leukemia survivors against the measles, mumps, and rubella vaccination.
Fouda AE; Kandil SM; Boujettif F; Salama YS; Fayea NY
Hematology; 2018 Oct; 23(9):590-595. PubMed ID: 29614919
[TBL] [Abstract][Full Text] [Related]
17. Vaccine-Derived Immunity in Children With Cancer-Analysis of Anti-Tetanus and Anti-Diphtheria Antibodies Changes after Completion of Antineoplastic Therapy.
Januszkiewicz-Lewandowska D; Gowin E; Bocian J; Zając-Spychała O; Małecka I; Stryczyńska-Kazubska J; Kałużna E; Avonts D; Wysocka-Leszczyńska J; Wysocki J
Pediatr Blood Cancer; 2015 Dec; 62(12):2108-13. PubMed ID: 26226936
[TBL] [Abstract][Full Text] [Related]
18. Loss of antibodies and response to (re-)vaccination in children after treatment for acute lymphocytic leukemia: a systematic review.
van Tilburg CM; Sanders EA; Rovers MM; Wolfs TF; Bierings MB
Leukemia; 2006 Oct; 20(10):1717-22. PubMed ID: 16888619
[TBL] [Abstract][Full Text] [Related]
19. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
Laws HJ; Calaminus G; Göbel U
Cancer; 2005 Apr; 103(8):1759; author reply 1760. PubMed ID: 15717299
[No Abstract] [Full Text] [Related]
20. Antibody status to poliomyelitis, measles, rubella, diphtheria and tetanus, Ontario, 1969-70: deficiencies discovered and remedies required.
MacLeod DR; Ing WK; Belcourt RJ; Pearson EW; Bell JS
Can Med Assoc J; 1975 Oct; 113(7):619-23. PubMed ID: 1181016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
